Patents by Inventor Stuart Norman

Stuart Norman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220042268
    Abstract: A pile (270) within a bore (110) comprises a column (250). The column (250) comprises a stack of a plurality of pile sections (300) arranged end-to-end within the bore (110). There is a cured material (260) between at least a part of an outside surface of the column (250) and the surface of the bore (110). The cured material, for example grout, may be provided through channels in the pile sections.
    Type: Application
    Filed: December 18, 2019
    Publication date: February 10, 2022
    Inventors: Paul Michael PELKEN, Stuart NORMAN
  • Patent number: 9059925
    Abstract: A method for multicast load balancing in a wireless network having a plurality of access points. The method includes setting a maximum Internet protocol multicast bandwidth for the access points, receiving an admissions control request from a client at one of the access points, and determining whether the admissions control request from the client is for an admitted or unadmitted multicast stream at the access point. The access point is responsive to the admissions control request for the admitted multicast stream by servicing the admitted multicast stream and to the admissions control request for the unadmitted multicast stream by servicing the unadmitted multicast stream where the bandwidth required for the unadmitted multicast stream, plus that portion of the access point bandwidth currently used for all existing downlink multicast streams, does not exceed the maximum internet protocol multicast bandwidth for the access point.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: June 16, 2015
    Assignee: Cisco Technology, Inc.
    Inventors: Robert C. Meier, Stuart Norman, Douglas A. Smith, Nancy Cam Winget
  • Patent number: 8436986
    Abstract: An apparatus (10) for assessment, evaluation and grading of gemstones has a stage (11) upon which a gemstone may be supported, the stage being enclosed in a housing (15) that is impervious to light. At least one light source (14) located in the housing is adapted to project incident light onto the gemstone. There are means for rotating and tilting the stage so as to vary the orientation of the gemstone to the incident light. A digital camera (16) is located in the housing adjacent the or each light source and is adapted to take images of the gemstone based on reflection and/or refraction of the incident light. There are also information processing means for calibrating and analyzing the images, with the information processing means being programmed with an instruction set for color calibrating the images and then analyzing the color calibrated images by segmentation and histogram measurement.
    Type: Grant
    Filed: April 2, 2008
    Date of Patent: May 7, 2013
    Assignee: Opal Producers Australia Limited
    Inventors: Graham Alfred Hornabrook, Stuart Norman Marchant, Rodney Herbert Lummis, Kathryn Elizabeth Primmer, Peter Bruce Sutton, Angus Nelson Hornabrook, Leanne Bischof, Ryan Lagerstrom, Volker Hilsenstein, Robert George Imrie
  • Publication number: 20130010669
    Abstract: A method for multicast load balancing in a wireless network having a plurality of access points. The method includes setting a maximum Internet protocol multicast bandwidth for the access points, receiving an admissions control request from a client at one of the access points, and determining whether the admissions control request from the client is for an admitted or unadmitted multicast stream at the access point. The access point is responsive to the admissions control request for the admitted multicast stream by servicing the admitted multicast stream and to the admissions control request for the unadmitted multicast stream by servicing the unadmitted multicast stream where the bandwidth required for the unadmitted multicast stream, plus that portion of the access point bandwidth currently used for all existing downlink multicast streams, does not exceed the maximum internet protocol multicast bandwidth for the access point.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 10, 2013
    Inventors: Robert C. MEIER, Stuart Norman, Douglas A. Smith, Nancy Cam Winget
  • Patent number: 8306027
    Abstract: A method for multicast load balancing in a wireless network having a plurality of access points. The method includes setting a maximum Internet protocol multicast bandwidth for the access points, receiving an admissions control request from a client at one of the access points, and determining whether the admissions control request from the client is for an admitted or unadmitted multicast stream at the access point. The access point is responsive to the admissions control request for the admitted multicast stream by servicing the admitted multicast stream and to the admissions control request for the unadmitted multicast stream by servicing the unadmitted multicast stream where the bandwidth required for the unadmitted multicast stream, plus that portion of the access point bandwidth currently used for all existing downlink multicast streams, does not exceed the maximum internet protocol multicast bandwidth for the access point.
    Type: Grant
    Filed: February 22, 2008
    Date of Patent: November 6, 2012
    Assignee: Cisco Technology, Inc.
    Inventors: Robert C. Meier, Stuart Norman, Douglas A. Smith, Nancy Cam Winget
  • Patent number: 8143263
    Abstract: A compound of Formula (I): is useful in the treatment or prevention of a disease or medical condition mediated through glucokinase (GLK or GK), leading to a decreased glucose threshold for insulin secretion.
    Type: Grant
    Filed: August 4, 2009
    Date of Patent: March 27, 2012
    Assignee: Astrazeneca AB
    Inventors: Stuart Norman Lile Bennett, Roger John Butlin, Leonie Campbell, Robert Darren Morse Davies, Graeme Richard Robb, Rolf Peter Walker, Michael James Waring, Helen Claire Pointon, Mikael Dan Brink, Jonas Rickard Fägerhag, Ulrik Jurva, Volker Schnecke, Anette Marie Svensson Henriksson, Christer Ralf Westerlund, Peter Gustaf Bonn
  • Patent number: 8071608
    Abstract: (2S)-2-[1-(2-Chloro-6-cyano-phenyl)pyrazolo[4,5-e]pyrimidin-4-yl]oxy-3-[(1R)-2-hydroxy-1-methyl-ethoxy]-N-(5-methylpyrazin-2-yl)propanamide or a pharmaceutically acceptable salt thereof is useful in the treatment or prevention of a disease or medical condition mediated through glucokinase (GLK or GK), leading to a decreased glucose threshold for insulin secretion.
    Type: Grant
    Filed: April 8, 2010
    Date of Patent: December 6, 2011
    Assignee: AstraZeneca AB
    Inventors: Stuart Norman Lile Bennett, Rolf Peter Walker, Michael James Waring
  • Publication number: 20110092526
    Abstract: A compound of formula (I): and pharmaceutically-acceptable salts thereof, wherein the variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are also described herein.
    Type: Application
    Filed: October 19, 2010
    Publication date: April 21, 2011
    Applicant: ASTRAZENECA AB
    Inventors: Stuart Norman Lile Bennett, Frederick Woolf Goldberg, Andrew Leach, Paul Robert Owen Whittamore, Pernilla Sörme
  • Publication number: 20100261733
    Abstract: (2S)-2-[1-(2-Chloro-6-cyano-phenyl)pyrazolo[4,5-e]pyrimidin-4-yl]oxy-3-[(1R)-2-hydroxy-1-methyl-ethoxy]-N-(5-methylpyrazin-2-yl)propanamide or a pharmaceutically acceptable salt thereof is useful in the treatment or prevention of a disease or medical condition mediated through glucokinase (GLK or GK), leading to a decreased glucose threshold for insulin secretion.
    Type: Application
    Filed: April 8, 2010
    Publication date: October 14, 2010
    Applicant: AstraZeneca AB
    Inventors: Stuart Norman Lile Bennett, Rolf Peter Walker, Michael James Waring
  • Publication number: 20100173958
    Abstract: Compounds of formula (I), or salts thereof, which inhibit acetyl CoA(acetyl coenzyme A):diacylglycerol acyltransferase (DGAT1) activity are provided, wherein, for example, R1 is optionally substituted phenyl or naphthyl; Ring A is selected from (3-6C)cycloalkyl, (5-12C)bicycloalkyl and phenyl; n is 0, 1 or 2; R2 is, for example, hydrogen, fluoro, chloro or hydroxy; Ring B is selected from (3-6C)cycloalkyl, (5-12C)bicycloalkyl and phenyl; L1 is a direct bond or a defined linker group and R3 is, for example, hydroxy, carboxy or (1-6C)alkoxycarbonyl; together with processes for their preparation, pharmaceutical compositions containing them and their use as medicaments.
    Type: Application
    Filed: June 8, 2007
    Publication date: July 8, 2010
    Inventors: Stuart Norman Lile Bennett, Roger John Butlin, Alleyn Thomas Plowright
  • Publication number: 20100111354
    Abstract: An apparatus (10) for assessment, evaluation and grading of gemstones has a stage (11) upon which a gemstone may be supported, the stage being enclosed in a housing (15) that is impervious to light. At least one light source (14) located in the housing is adapted to project incident light onto the gemstone. There are means for rotating and tilting the stage so as to vary the orientation of the gemstone to the incident light. A digital camera (16) is located in the housing adjacent the or each light source and is adapted to take images of the gemstone based on reflection and/or refraction of the incident light. There are also information processing means for calibrating and analysing the images, with the information processing means being programmed with an instruction set for colour calibrating the images and then analysing the colour calibrated images by segmentation and histogram measurement.
    Type: Application
    Filed: April 2, 2008
    Publication date: May 6, 2010
    Applicant: OPAL PRODUCERS AUSTRALIA LIMITED
    Inventors: Graham Alfred Hornabrook, Stuart Norman Marchant, Rodney Herbert Lummis, Kathryn Elizabeth Primmer, Peter Bruce Sutton, Angus Nelson Hornabrook, Leanne Bischof, Ryan Lagerstrom, Volker Hilsenstein, Robert George Imrie
  • Publication number: 20100093757
    Abstract: A compound of Formula (I): is useful in the treatment or prevention of a disease or medical condition mediated through glucokinase (GLK or GK), leading to a decreased glucose threshold for insulin secretion.
    Type: Application
    Filed: August 4, 2009
    Publication date: April 15, 2010
    Applicant: AstraZeneca AB
    Inventors: Stuart Norman Lile BENNETT, Roger John Butlin, Leonie Campbell, Robert Darren Morse Davies, Graeme Richard Robb, Rolf Peter Walker, Michael James Waring, Helen Claire Pointon, Mikael Dan Brink, Jonas Rickard Fägerhag, Ulrik Jurva, Volker Schnecke, Anette Marie Svensson Henriksson, Christer Ralf Westerlund, Peter Gustaf Bonn
  • Publication number: 20080151807
    Abstract: A method for multicast load balancing in a wireless network having a plurality of access points. The method includes setting a maximum Internet protocol multicast bandwidth for the access points, receiving an admissions control request from a client at one of the access points, and determining whether the admissions control request from the client is for an admitted or unadmitted multicast stream at the access point. The access point is responsive to the admissions control request for the admitted multicast stream by servicing the admitted multicast stream and to the admissions control request for the unadmitted multicast stream by servicing the unadmitted multicast stream where the bandwidth required for the unadmitted multicast stream, plus that portion of the access point bandwidth currently used for all existing downlink multicast streams, does not exceed the maximum internet protocol multicast bandwidth for the access point.
    Type: Application
    Filed: February 22, 2008
    Publication date: June 26, 2008
    Inventors: Robert C. Meier, Stuart Norman, Douglas A. Smith, Nancy Cam Winget
  • Patent number: 7362776
    Abstract: A method for multicast load balancing in a wireless network having a plurality of access points. The method includes setting a maximum Internet protocol multicast bandwidth for the access points, receiving an admissions control request from a client at one of the access points, and determining whether the admissions control request from the client is for an admitted or unadmitted multicast stream at the access point. The access point is responsive to the admissions control request for the admitted multicast stream by servicing the admitted multicast stream and to the admissions control request for the unadmitted multicast stream by servicing the unadmitted multicast stream where the bandwidth required for the unadmitted multicast stream, plus that portion of the access point bandwidth currently used for all existing downlink multicast streams, does not exceed the maximum internet protocol multicast bandwidth for the access point.
    Type: Grant
    Filed: November 1, 2004
    Date of Patent: April 22, 2008
    Assignee: Cisco Technology, Inc.
    Inventors: Robert C. Meier, Stuart Norman, Douglas A. Smith, Nancy Cam Winget
  • Publication number: 20080066350
    Abstract: The present application relates to a method and apparatus for excavating soil from the ground to form a hole or trench. The tool is provided with a plurality of excavation members which are caused to penetrate the ground in order that soil may be excavated. The direction of excavation of the tool may be adjusted by the use of one or more steering members (10), the or each steering member comprising a steering element (11) which is disposed, or is operable to be disposed, such that the initial point of contact of the steering element with the ground allows the direction of excavation of the tool to be adjusted. Provides a simple, but effective, mechanical means to adjust the direction of excavation. The steering element may comprise a plate which is angled such that at the point of contact with the ground, the steering members may gently divert the grab in the desired direction. Thus, in this way, any deviation in the direction of excavation can be corrected or at least countered.
    Type: Application
    Filed: August 18, 2005
    Publication date: March 20, 2008
    Inventors: Robert Humphries, Stuart Norman
  • Publication number: 20080064691
    Abstract: A compound of the formula (1) or a pharmaceutically-acceptable salt, or pro-drug thereof; wherein, for example, Z is CH or nitrogen, R4 and R5 together are either —S—C(R6)?C(R7)— or —C(R7)?C(R6)—S—; R6 and R7 are independently selected from hydrogen, halo, nitro, cyano, hydroxy, fluoromethyl, difluoromethyl, trifluoromethyl, trifluoromethoxy, carboxy and carbamoyl; A is phenylene or heteroarylene; n is 0, 1 or 2; r is 1 or 2; R1 is halo, cyano or carboxy; Y is selected from —C(O)R2, —C(O)OR2, —C(O)NR2R3, -(1-4C)alkyl [optionally substituted] -(2-4C)alkenyl, —SO2NR2R3, and —S(O)cR2 (wherein c is 0, 1 or 2); R2 and R3 are independently selected from hydrogen, —O(1-4C)alkyl, —S(1-4C)alkyl, —N(1-4C)alkyl, heterocyclyl, aryl, and (1-4C)alkyl [optionally substituted]; possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity.
    Type: Application
    Filed: August 4, 2004
    Publication date: March 13, 2008
    Applicant: AstraZeneca AB
    Inventors: Alan Martin Birch, Stuart Norman Lile Bennett, Andrew Duncan Campbell, Iain Simpson, Paul Robert Owen Whittamore, David Paul Whalley, Linda Godfrey
  • Patent number: 7188253
    Abstract: A wireless authentication protocol. Access to a network is managed by providing a challenge-handshake protocol within the Extensible Authentication Protocol for authentication between a client and the network.
    Type: Grant
    Filed: February 6, 2006
    Date of Patent: March 6, 2007
    Assignee: Cisco Technology, Inc.
    Inventors: David E. Halasz, Glen W. Zorn, Stuart Norman, Douglas Smith
  • Patent number: 7138415
    Abstract: Heterocyclic amides of formula (1) wherein: is a single or double bond; A is phenylene or heteroarylene; m is 0, 1 or 2; n is 0, 1 or 2; R1 is selected from for example halo, nitro, cyano, hydroxy, carboxy; r is 1 or 2; Y is —NR2R3 or —OR3; R2 and R3 are selected from for example hydrogen, hydroxy, aryl, heterocyclyl and C1-4alkyl(optionally substituted by 1 or 2 R8 groups); R4 is selected from for example hydrogen, halo, nitro, cyano, hydroxy, C1-4alkyl, and C1-4alkanoyl; R8 is selected from for example hydroxy, —COCOOR9, —C(O)N(R9)(R9), —NHC(O)R9, (R9)(R10)N— and —COOR9; R9 and R10 are selected from for example hydrogen, hydroxy, C1-4alkyl (optionally substituted by 1 or 2 R13); R13 is selected from hydroxy, halo, trihalomethyl and C1-4alkoxy; or a pharmaceutically acceptable salt or pro-drug thereof; possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity.
    Type: Grant
    Filed: March 4, 2003
    Date of Patent: November 21, 2006
    Assignee: AstraZeneca AB
    Inventors: Paul Robert Owen Whittamore, Stuart Norman Lile Bennett, Iain Simpson
  • Patent number: 7122567
    Abstract: Heterocyclic amides of formula (1) wherein: Z is CH or nitrogen; R4 and R5 together are either —S—C(R6)?C(R7)— or —C(R7)?C(R6)—S—; R6 and R7 are selected from for example hydrogen, halo, C1-4alkyl, and C1-4alkanoyl; A is phenylene or heteroarylene; n is 0, 1 or 2; R1 is selected from for example halo, nitro, cyano, hydroxy, carboxy; r is 1 or 2; Y is —NR2R3 or —OR3; R2 and R3 are selected from for example hydrogen, hydroxy, aryl, heterocyclyl and C1-4alkyl(optionally substituted by 1 or 2 R8 groups); R4 is selected from for example hydrogen, halo, nitro, cyano, hydroxy, C1-4alkyl, and C1-4alkanoyl; R8 is selected from for example hydroxy, —COCOOR9, —C(O)N(R9)(R10), —NHC(O)R9, (R9)(R10)N— and —COOR9; R9 and R10 are selected from for example hydrogen, hydroxy, C1-4alkyl (optionally substituted by 1 or 2 R13); R13 is selected from hydroxy, halo, trihalomethyl and C1-4alkoxy; or a pharmaceutically acceptable salt or pro-drug thereof; possess glycogen phosphorylase inhibitory activity and accordingly have va
    Type: Grant
    Filed: March 4, 2003
    Date of Patent: October 17, 2006
    Assignee: AstraZeneca AB
    Inventors: Paul Whittamore, Stuart Norman Lile Bennett, Iain Simpson
  • Publication number: 20060199966
    Abstract: A compound of the formula (1) or a pharmaceutically-acceptable salt, or pro-drug thereof; (1) wherein, for example, R4 is halo or (1-4C)alkyl; A is phenylene or heteroarylene; n is 0, 1 or 2; m is 0, 1 or 2; R1 is halo, cyano or carboxy; R2 is for example methyl; R3 is for example selected from halo(1-4C)alkyl, dihalo(1-4C)alkyl, trifluoromethyl, hydroxy(1-4C)alkyl, dihydroxy(2-4C)alkyl, trihydroxy(3-4C)alkyl, cyano(1-4C)alkyl (optionally substituted on alkyl with hydroxy), (1-4C)alkoxy(1-4C)alkyl, (1-4C)alkoxy(1-4C)alkoxy(1-4C)alkyl, di[(1-4C)alkoxy](1-4C)alkyl, (hydroxy)[(1-4C)alkoxy](1-4C)alkyl; possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity. Processes for the manufacture of compounds and pharmaceutical compositions containing them are described.
    Type: Application
    Filed: August 18, 2004
    Publication date: September 7, 2006
    Applicant: AstraZeneca AB
    Inventors: Stuart Norman Bennett, Iain Simpson, Paul Robert Owen Whittamore